The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Inflammatory Markers and Poor Outcome after Stroke: A Prospective Cohort Study and Systematic Review of Interleukin-6
Open accessAbstract
BACKGROUND: The objective of this study was to determine whether: (a) markers of acute inflammation (white cell count, glucose, interleukin-6, C-reactive protein, and fibrinogen) are associated with poor outcome after stroke and (b) the addition of markers to previously validated prognostic models improves prediction of poor outcome. METHODS AND FINDINGS: We prospectively recruited patients between 2002 and 2005. Clinicians assessed patients and drew blood for inflammatory markers. Patients were followed up by postal questionnaire for poor outcome (a score of>2 on the modified Rankin Scale) and death through the General Register Office (Scotland) at 6 mo. We performed a systematic review of the literature and meta-analysis of the association between interleukin-6 and poor outcome after stroke to place our study in the context of previous research. We recruited 844 patients; mortality data were available in 844 (100%) and functional outcome in 750 (89%). After appropriate adjustment, the odds ratios for the association of markers and poor outcome (comparing the upper and the lower third) were interleukin-6, 3.1 (95% CI: 1.9-5.0); C-reactive protein, 1.9 (95% CI: 1.2-3.1); fibrinogen, 1.5 (95% CI: 1.0-2.36); white cell count, 2.1 (95% CI: 1.3-3.4); and glucose 1.3 (95% CI: 0.8-2.1). The results for interleukin-6 were similar to other studies. However, the addition of inflammatory marker levels to validated prognostic models did not materially improve model discrimination, calibration, or reclassification for prediction of poor outcome after stroke. CONCLUSIONS: Raised levels of markers of the acute inflammatory response after stroke are associated with poor outcomes. However, the addition of these markers to a previously validated stroke prognostic model did not improve the prediction of poor outcome. Whether inflammatory markers are useful in prediction of recurrent stroke or other vascular events is a separate question, which requires further study. Please see later in the article for the Editors' Summary.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dermyshi, E., Wang, Y., Yan, C., Hong, W., Qiu, G., Gong, X., & Zhang, T. (2017) · Neonatology · doi:10.1159/000454668 · Cited by 24,451
von Elm, E., Altman, D. G., Egger, M., Pocock, S. J., Gøtzsche, P. C., Vandenbroucke, J. P., & Initiative, F. T. S. (2007) · PLoS Medicine · doi:10.1371/journal.pmed.0040296 · Cited by 23,020
von Elm, E., Altman, D. G., Egger, M., Pocock, S. J., Gøtzsche, P. C., & Vandenbroucke, J. P. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61602-x · Cited by 21,320
Meta-analysis of Observational Studies in Epidemiology<SUBTITLE>A Proposal for Reporting</SUBTITLE>
Stroup, D. F. (2000) · JAMA · doi:10.1001/jama.283.15.2008 · Cited by 20,623
Pencina, M. J., D' Agostino, R. B., D' Agostino, R. B., & Vasan, R. S. (2008) · Statistics in Medicine · doi:10.1002/sim.2929 · Cited by 6,493 · cited 1×
“[10] to calculate net reclassification improvement (NRI).”
Measurements of acute cerebral infarction: a clinical examination scale.
Brott, T., Adams, H. P., Olinger, C. P., Marler, J. R., Barsan, W. G., Biller, J., Spilker, J., Holleran, R., Eberle, R., & Hertzberg, V (1989) · Stroke · doi:10.1161/01.str.20.7.864 · Cited by 5,911
Classification and natural history of clinically identifiable subtypes of cerebral infarction
Bamford, J., Sandercock, P., Dennis, M., Warlow, C., & Burn, J. (1991) · The Lancet · doi:10.1016/0140-6736(91)93206-o · Cited by 3,294
Self-citationUse and Misuse of the Receiver Operating Characteristic Curve in Risk Prediction
Cook, N. R. (2007) · Circulation · doi:10.1161/circulationaha.106.672402 · Cited by 2,112
. Inflammatory and coagulation biomarkers and mortality in patients with HIV infection.
Kuller, L. H., Tracy, R., Belloso, W., Wit, S. D., Drummond, F., Lane, H. C., Ledergerber, B., Lundgren, J., Neuhaus, J., Nixon, D., et al. (2008) · PLoS Medicine · doi:10.1371/journal.pmed.0050203 · Cited by 1,617
Pepe, M. S. (2004) · American Journal of Epidemiology · doi:10.1093/aje/kwh101 · Cited by 1,276
Reporting Recommendations for Tumor Marker Prognostic Studies
McShane, L. M., Altman, D. G., Sauerbrei, W., Taube, S. E., Gion, M., & Clark, G. M. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2004.01.0454 · Cited by 779
Systematic reviews of evaluations of prognostic variables
Altman, D. G. (2001) · BMJ · doi:10.1136/bmj.323.7306.224 · Cited by 756
Danesh, J., Kaptoge, S., Mann, A. G., Sarwar, N., Wood, A., Angleman, S. B., Wensley, F., Higgins, J. P. T., Lennon, L., Eiriksdottir, G., et al. (2008) · PLoS Medicine · doi:10.1371/journal.pmed.0050078 · Cited by 676
Self-citationSmith, C. J., Emsley, H. C., Gavin, C. M., Georgiou, R. F., Vail, A., Barberan, E. M., del Zoppo, G. J., Hallenbeck, J. M., Rothwell, N. J., Hopkins, S. J., et al. (2004) · BMC Neurology · doi:10.1186/1471-2377-4-2 · Cited by 480
Interleukin‐6 predicts recurrence and survival among head and neck cancer patients
Duffy, S. A., Taylor, J. M. G., Terrell, J. E., Islam, M., Li, Y., Fowler, K. E., Wolf, G. T., & Teknos, T. N. (2008) · Cancer · doi:10.1002/cncr.23615 · Cited by 330
Counsell, C., Dennis, M., McDowall, M., & Warlow, C. (2002) · Stroke · doi:10.1161/hs0402.105909 · Cited by 319
Self-citationBlood Markers for the Prognosis of Ischemic Stroke: A Systematic Review
Whiteley, W., Chong, W. L., Sengupta, A., & Sandercock, P. (2009) · Stroke · doi:10.1161/strokeaha.108.528752 · Cited by 290
Self-citationLevels of Anti-Inflammatory Cytokines and Neurological Worsening in Acute Ischemic Stroke
Vila, N., Castillo, J., Dávalos, A., Esteve, A., Planas, A. M., & Chamorro, A. (2003) · Stroke · doi:10.1161/01.str.0000057976.53301.69 · Cited by 282
Molecular signatures of brain injury after intracerebral hemorrhage
Castillo, J., Dávalos, A., Álvarez–Sabín, J., Pumar, J. M., Leira, R., Silva, Y., Montaner, J., & Kase, C. S. (2002) · Neurology · doi:10.1212/wnl.58.4.624 · Cited by 274
König, I. R., Ziegler, A., Bluhmki, E., Hacke, W., Bath, P. M. W., Sacco, R. L., Diener, H. C., & Weimar, C. (2008) · Stroke · doi:10.1161/strokeaha.107.505867 · Cited by 259
Assessing the Value of Risk Predictions by Using Risk Stratification Tables
Janes, H., Pepe, M. S., & Gu, W. (2008) · Annals of Internal Medicine · doi:10.7326/0003-4819-149-10-200811180-00009 · Cited by 249
IL-6: an early marker for outcome in acute ischemic stroke
Waje-Andreassen, U., Krakenes, J., Ulvestad, E., Thomassen, L., Myhr, K.-M., Aarseth, J., & Vedeler, C. A. (2005) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.2005.00416.x · Cited by 228
Catecholamines, infection, and death in acute ischemic stroke
Chamorro, Á., Amaro, S., Vargas, M., Obach, V., Cervera, Á., Gómez-Choco, M., Torres, F., & Planas, A. M. (2007) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2006.10.001 · Cited by 192
Lack of Interleukin-6 Expression Is Not Protective Against Focal Central Nervous System Ischemia
Clark, W. M., Rinker, L. G., Lessov, N. S., Hazel, K., Hill, J. K., Stenzel-Poore, M., & Eckenstein, F. (2000) · Stroke · doi:10.1161/01.str.31.7.1715 · Cited by 187
Inflammatory biomarkers in blood of patients with acute brain ischemia
Sotgiu, S., Zanda, B., Marchetti, B., Fois, M. L., Arru, G., Pes, G. M., Salaris, F. S., Arru, A., Pirisi, A., & Rosati, G. (2006) · European Journal of Neurology · doi:10.1111/j.1468-1331.2006.01280.x · Cited by 176
Associations of Proinflammatory Cytokines With the Risk of Recurrent Stroke
Welsh, P., Lowe, G. D. O., Chalmers, J., Campbell, D. J., Rumley, A., Neal, B. C., MacMahon, S. W., & Woodward, M. (2008) · Stroke · doi:10.1161/strokeaha.107.504498 · Cited by 159
Self-citationKes, V. B., Šimundić, A.-M., Nikolac, N., Topić, E., & Demarin, V. (2008) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2008.08.080 · Cited by 147
Associations of Inflammatory and Haemostatic Biomarkers with Poor Outcome in Acute Ischaemic Stroke
Welsh, P. I., Barber, M., Langhorne, P., Rumley, A., Lowe, G. D. O., & Stott, D. J. (2009) · Cerebrovascular Diseases · doi:10.1159/000196823 · Cited by 139
Self-citationCan Simple Questions Assess Outcome after Stroke?
Lindley, R. I., Waddell, F., Livingstone, M., Sandercock, P. A., Dennis, M. S., Slattery, J., Smith, B., & Warlow, C. P. (1994) · Cerebrovascular Diseases · doi:10.1159/000108501 · Cited by 132
Self-citationAssociations of Inflammatory and Hemostatic Variables With the Risk of Recurrent Stroke
Woodward, M., Lowe, G. D. O., Campbell, D. J., Colman, S., Rumley, A., Chalmers, J. P., Neal, B. C., Patel, A. A., Jenkins, A. J., Kemp, B. E., et al. (2005) · Stroke · doi:10.1161/01.str.0000181754.38408.4c · Cited by 129
Self-citationPredictors of good outcome in medium to large spontaneous supratentorial intracerebral haemorrhages
Castellanos, M. (2005) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2004.044347 · Cited by 127
Inflammatory markers and in-hospital mortality in acute ischaemic stroke
Rallidis, L. S., Vikelis, M., Panagiotakos, D. B., Rizos, I. K., Zolindaki, M., Kaliva, K., & Kremastinos, D. T. (2006) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2005.11.032 · Cited by 96
The impact of inflammation on the pathogenesis and prognosis of ischemic stroke
Nakase, T., Yamazaki, T., Ogura, N., Suzuki, A., & Nagata, K. (2008) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2008.03.020 · Cited by 95
Different cytokine levels in thrombolysis patients as predictors for clinical outcome
Mazzotta, G. M., Sarchielli, P., Caso, V., Paciaroni, M., Floridi, A., Floridi, A., & Gallai, V. (2004) · European Journal of Neurology · doi:10.1111/j.1468-1331.2004.00798.x · Cited by 77
Early signaling of inflammation in acute ischemic stroke: Clinical and rheological implications
Shenhar‐Tsarfaty, S., Assayag, E. B., Bova, I., Shopin, L., Berliner, S. A., Shapira, I., & Bornstein, N. M. (2007) · Thrombosis Research · doi:10.1016/j.thromres.2007.10.019 · Cited by 31
Tumor necrosis factor alpha serum levels and inflammatory response in acute ischemic stroke
Domaç, F. M., Somay, G., Mısırlı, H., & Erenoğlu, N. Y. (2007) · Neurosciences · doi:10.17712/1658-3183.1463 · Cited by 26
Assessing the impact of the requirement for explicit consent in a hospital-based stroke study
Jackson, C., Crossland, L., Dennis, M. S., Wardlaw, J. M., & Sudlow, C. L. M. (2008) · QJM · doi:10.1093/qjmed/hcm152 · Cited by 25
Self-citation
Cited by
Inflammatory Cytokines in Experimental and Human Stroke
Lambertsen, K. L., Biber, K., & Finsen, B. (2012) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2012.88 · Cited by 732
Functional differences between microglia and monocytes after ischemic stroke
Ritzel, R. M., Patel, A. R., Grenier, J. M., Crapser, J., Verma, R., Jellison, E. R., & McCullough, L. D. (2015) · Journal of Neuroinflammation · doi:10.1186/s12974-015-0329-1 · Cited by 295
“Inflammation is a key component of stroke-induced injury and elevated levels of inflammatory markers are associated with poor outcome in stroke patients [1–4].”
BackgroundUse of reclassification for assessment of improved prediction: an empirical evaluation
Tzoulaki, I., Liberopoulos, G., & Ioannidis, J. P. A. (2011) · International Journal of Epidemiology · doi:10.1093/ije/dyr013 · Cited by 70
Bahjat, F. R., Williams-Karnesky, R. L., Kohama, S. G., West, G. A., Doyle, K. P., Spector, M. D., Hobbs, T. R., & Stenzel-Poore, M. P. (2011) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2011.6 · Cited by 51
Metadata
- Authors
- Whiteley, W., Jackson, C., Lewis, S., Lowe, G., Rumley, A., Sandercock, P., Wardlaw, J., Dennis, M., & Sudlow, C.
- Venue
- PLoS Medicine
- Publisher
- Public Library of Science (PLoS)
- Published
- 2009-09-08
- Volume
- 6
- Issue
- 9
- Pages
- e1000145
- ISSN
- 1549-1277 (ISSN-L)
- 1549-1676
- OpenAlex
- W2048350854
- Cited by
- 279
- References
- 37
- FWCI
- 2.13
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.